Valve Disease Flashcards
Aortic Stenosis: indications for the surgery in the symptomatic patients
- High Gradient AS
- Low flow AS that shows velocity > 4 or transvalvular gradient 40mmHg or AVA < 1.0
- Normotensive, EF> 50% if stenosis is the likely the cause of symptoms (with acceptable operative risk
Aortic stenosis - indications for surgery in asymptomatic patients
- Severe AS with EF < 50
- Severe AS undergoing another surgery
- Severe AS with > 5.0 velocity lows surgicalrisk
- Rapid progression
IB Recs for surgery for AS
- Hi Gradient AS - Severe AS with EF < 50% - Severe AS with velocity > 5.0 - Moderate AS wundergoing annother surgery
Recs for surgery for AS if undergoing another cardiac surgery
IB - severe AS undergoing another surgery
IIA- moderate AS (velocity between 3.0-3.9) undergoing another surgery
Number of Major Duke criteria for definite diagnosis of Endocarditis
2
Number of Duke minor criteria (only) for definite endocarditis
5
Number of Duke minor criteria (only) for probable endocarditis
3
Number of Duke major and minor criteria for probable endocarditis
1 major and 1 minor
Number of Duke major and minor criteria for definite endocarditis
1 major and 3 minor
Duke Minor Criteria
- Predisposing Heart condition
- IVDA
- Fever > 100.4
- Vascular phenomiena - septic embloli, mycotic aneurysm
- Immunologic pheomena (glomerular nephritis, Osler node, Roth spots, rheumatoid factor
- Blood culture not meeting criteria
Class I recomendations for surgery for endocarditis
- Early surgery (before completion of abx) in patients with valve dysfuction leading to heart failure
- Patients with left sided lesions with highly resistent organisms such as Staph aureus or fungal
- early surgery with heart block or abscess
- Recurrent prosthetic valve endocarditis
Blood cx organisms meeting major criteria for IE
- Strep viridans
- Strep bovis
- Staph aureus
- HAECK organism
- Comiunity acquried enterococci
PARTNERS 1 procedural success rate
95%
Partners 1 - 30 day mortality rate
- 4% - Sapien
- 5% - Surgery (p- 0.07)
Partners 1 trial 1 year mortality
24% Sapien
27% Surgery (p - 0.44)